AbbVie AIDS drug clears pre-cancerous lesions in Kenyan study

AbbVie Inc.'s AIDS drug Kaletra cleared pre-cancerous cervical lesions from 90 percent of patients in a study in Kenya that may lead to the first non-surgical treatment to prevent a disease that kills a woman every two minutes.

http://ift.tt/O2hqdT